| Grant number: | 09/15386-6 |
| Support Opportunities: | Scholarships in Brazil - Post-Doctoral |
| Start date: | May 01, 2010 |
| End date: | April 30, 2012 |
| Field of knowledge: | Health Sciences - Medicine - Medical Clinics |
| Principal Investigator: | Maria Candida Barisson Villares Fragoso |
| Grantee: | Rodrigo de Almeida Toledo |
| Host Institution: | Faculdade de Medicina (FM). Universidade de São Paulo (USP). São Paulo , SP, Brazil |
Abstract Multiple endocrine neoplasias (MENs) are tumoral familial syndromes which involve several endocrine glands (pituitary, parathyroids, thyroid, endocrine pancreas and adrenal). Patients with MEN type 1 (MEN1) usually carry inactivating mutations in the MEN1 gene, while patients with MEN type 2 (MEN2) usually carry activating mutations in the RET proto-oncogene. Recently, patients with MENs but not carrying MEN1 and RET mutations were reported with rare germline mutations in the CDKN1A, CDKN1B, CDKN2B and CDKN2C tumor suppressor genes, which encodes for the cyclin-dependent kinase inhibitors (p15, p18, p21 and p27, respectively). The role of these genes in the clinical features of patients harboring disease-causing RET or MEN1 mutations has not been investigated so far. In the current study, we sought to analyze these new MEN-related tumor suppressor genes in RET- and MEN1-mutated patients, in order to clarify whether they play a role in the susceptibility and tumorigenesis of endocrine tumors in these patients. | |
| News published in Agência FAPESP Newsletter about the scholarship: | |
| More itemsLess items | |
| TITULO | |
| Articles published in other media outlets ( ): | |
| More itemsLess items | |
| VEICULO: TITULO (DATA) | |
| VEICULO: TITULO (DATA) | |